Email
Print
The
Cysticercosis Treatment Market deals with the development of medical technology especially for providing better treatment of cysticercosis. Cysticercosis, is an infection caused by the Taenia solium variety of tapeworms which are found in pork, which is also known as taeniasis.
Basically, this infection occurs when the tapeworm larvae enter the body and form cysticerci. It can develop in humans which causes fever, myositis and muscular pseudo-hypertrophy. In many cases, dramatic weight loss can be observed because of diarrhea and in severe cases, the pathogen can cause neurocysticercosis. Probably, it is often found in rural and developing countries with poor hygiene where pigs are allowed to roam freely and ingest human faeces. Globally, rise in the incidences of cysticercosis in many regions is the major key growth factor of the Cysticercosis Treatment Market.
Increasing government initiative to eradicate Cysticercosis and growing awareness among people for Cysticercosis are the primary growth drivers of the Cysticercosis Treatment Market. In addition, increase in adoption of cysticercosis treatment or teniasis treatment in emerging economies like India and China creating new growth opportunities for the market.
Among all the treatments, albendazole is having the highest share in the market of cysticercosis treatment. However, higher cost of the research and development, high frequency of adverse reactions, the body’s inflammatory reaction to the dying parasites are the key restraints for Cysticercosis Treatment Market.
Latin America is dominating the Cysticercosis Treatment Market, due to rapidly increasing incidences of Cysticercosis. Asia-Pacific is projected to witness the fastest growth due to awareness among people and government regulations in developing nations like India and China in this region. Also, these two regions are expected to continue their growth during the forecast period, followed by Europe and Rest of the World.
Basically, this infection occurs when the tapeworm larvae enter the body and form cysticerci. It can develop in humans which causes fever, myositis and muscular pseudo-hypertrophy. In many cases, dramatic weight loss can be observed because of diarrhea and in severe cases, the pathogen can cause neurocysticercosis. Probably, it is often found in rural and developing countries with poor hygiene where pigs are allowed to roam freely and ingest human faeces. Globally, rise in the incidences of cysticercosis in many regions is the major key growth factor of the Cysticercosis Treatment Market.
Increasing government initiative to eradicate Cysticercosis and growing awareness among people for Cysticercosis are the primary growth drivers of the Cysticercosis Treatment Market. In addition, increase in adoption of cysticercosis treatment or teniasis treatment in emerging economies like India and China creating new growth opportunities for the market.
Among all the treatments, albendazole is having the highest share in the market of cysticercosis treatment. However, higher cost of the research and development, high frequency of adverse reactions, the body’s inflammatory reaction to the dying parasites are the key restraints for Cysticercosis Treatment Market.
Latin America is dominating the Cysticercosis Treatment Market, due to rapidly increasing incidences of Cysticercosis. Asia-Pacific is projected to witness the fastest growth due to awareness among people and government regulations in developing nations like India and China in this region. Also, these two regions are expected to continue their growth during the forecast period, followed by Europe and Rest of the World.
Browse Related Reports:
- Teleradiology Market: By Product (X-ray, Computed Tomography, Ultrasound, Nuclear Imaging, Magnetic Resonance Imaging), By Application (Tele-consulting, Tele-diagnosis) By Category (Hardware, Software) & By Region-Forecast (2016-2021)
https://www.industryarc.com/Report/16287/teleradiology-market.html
- Bacterial Conjunctivitis Treatment Market: By Infection (Neonatal Conjunctivitis, Adult Gonococcal Conjunctivitis, Trachoma); By Antibacterial Class (Fluoroquinolones, Aminoglycosides, Macrolides, Others); By Method (Ointments, Eye Drops, Drugs) & By Geography-Forecast (2016-2021)
https://www.industryarc.com/Report/15943/bacterial-conjunctivitis-treatment-market.html
About IndustryARC:
IndustryARC
is a research and consulting firm that publishes more than 500 reports
annually in various industries, such as Agriculture, Automotive,
Automation & Instrumentation, Chemicals and Materials, Energy and
Power, Electronics, Food & Beverages, Information Technology, Life
sciences & Healthcare.
IndustryARC
primarily focuses on Cutting Edge Technologies and Newer Applications
of the Market. Our Custom Research Services are designed to provide
insights on the constant flux in the global demand-supply gap of
markets. Our strong analyst team enables us to meet the client research
needs at a very quick speed with a variety of options for your business.
We
look forward to support the client to be able to better address
customer needs; stay ahead in the market; become the top competitor and
get real-time recommendations on business strategies and deals. Contact
us to find out how we can help you today.
Contact Us:
Mr. Venkateshwar Reddy
Business Development Manager
Email: [email protected]
Contact Sales: 1-614-588-8538 (Ext-101)